Plasma 25-Hydroxyvitamin D Levels and Survival in Patients with
Advanced or Metastatic Colorectal Cancer: Findings from CALGB/SWOG 80405
(Alliance)
- Citation:
- Clin. Cancer Res. vol 25 (24) 7497-7505
- Year:
- 2019
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- Alliance-data-source,-internal-user
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Pharmas:
- Genentech; Sanofi; Pfizer; BMS
- Grants:
- U10CA180821, U10CA180882, U10CA180795, U10CA180838, U10CA180867, UG1CA189858, K07CA148894, P50CA127003, R01CA118553, R01CA205406, U10CA180826, U10CA180830, U10CA180888, U24CA196171
- Corr. Author:
- Authors:
- Chen Yuan Kaori Sato Bruce W. Hollis Sui Zhang Donna Niedzwiecki Fang-Shu Ou I-Wen Chang Bert H. O'Neil Federico Innocenti Heinz-Josef Lenz Charles D. Blanke Richard M. Goldberg Alan P. Venook Robert J. Mayer Charles S. Fuchs Jeffrey A. Meyerhardt Kimmie Ng
- Networks:
- CA011, CA824, GA032, LAPS-CT018, LAPS-IN007, LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-OH007, OR013
- Study
- Alliance-A151738
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-80405
- Phases:
- N/A, 3
- Keywords:
- 25-hydroxyvitamin D, colorectal cancer, survival